Date,Agency,Category,Title,Link
9. February 2026,Central Drugs Standard Control Organization,Guidance,Central Drugs Standard Control Organization Draft Guidance for Import of In-Vitro Diagnostic Medical Devices,https://www.linkedin.com/feed/update/urn:li:activity:7424699184278065152/
9. February 2026,Egyptian Drug Authority,Guidance,Egyptian Drug Authority Role of Oncology Pharmacist in Personalized Medication Management Establishes the formal role of oncology pharmacists in precision (personalized) medicine delivery,https://www.linkedin.com/feed/update/urn:li:activity:7424697091588968448/
9. February 2026,Medical Device Authority,Announcement,"Medical Device Authority Implementation of Electronic Certificates for Certificate of Free Sale, Manufacturing Certificate, and Export Certificate",https://www.linkedin.com/feed/update/urn:li:activity:7424700979058737152/
9. February 2026,European Medicines Agency (EMA),Guidance,European Medicines Agency List of CECP opinions issued for medical devices awaiting finalisation of conformity assessment This aims to increase transparency on Expert Panel CECP opinions issued for medical devices under EU conformity assessment,https://www.linkedin.com/feed/update/urn:li:activity:7424777725472706560/
9. February 2026,European Medicines Agency,Guidance,European Medicines Agency Registration Guide for UI and API Users Union Product Database (UPD),https://www.linkedin.com/feed/update/urn:li:activity:7424323402171064320/
9. February 2026,European Medicines Agency,Meeting,Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 26-29 January 2026,https://www.linkedin.com/feed/update/urn:li:activity:7423972773082861568/
9. February 2026,European Commission,Standards,European Commission Implementing Decision (EU) 2026/193 of 28 January 2026,https://www.linkedin.com/feed/update/urn:li:activity:7424343601226108928/
9. February 2026,European Commission,Standards,European Commission Implementing Decision (EU) 2026/197 of 28 January 2026,https://www.linkedin.com/feed/update/urn:li:activity:7424345959154991105/
9. February 2026,Health Canada,Guidance,Regulatory enrolment process (REP) Describes Health Canadas Regulatory Enrolment Process (REP) for filing and processing regulatory information,https://www.linkedin.com/feed/update/urn:li:activity:7422911205465382913/
9. February 2026,"Department of Health, HKSAR Government",Guidance,TR-007:2026(E) - Software Medical Devices and Cybersecurity under MDACS,https://www.linkedin.com/feed/update/urn:li:activity:7425057511973650432/
9. February 2026,"Department of Health, HKSAR Government",Guidance,TR-008:2026(E) - Artificial Intelligence Medical Devices (AI-MD),https://www.linkedin.com/feed/update/urn:li:activity:7425059648552017920/
9. February 2026,ISO (International Organization for Standardization),Standards,ISO Update January 1. to February 1. 2026,https://www.linkedin.com/feed/update/urn:li:activity:7424825847058169857/
9. February 2026,Medical Device Single Audit Program MDSAP,Guidance,MDSAP Audit Approach (AU P0002.10),https://www.linkedin.com/feed/update/urn:li:activity:7424330858477559808/
9. February 2026,MedTech Europe,Newsletter,MedTech Europe Driving Value in Healthcare: Scaling Up Value-Based Procurement across Europe,https://www.linkedin.com/feed/update/urn:li:activity:7424813999638159361/
9. February 2026,South African Health Products Regulatory Authority,Guidance,Amendment of a Medical Device Establishment Licence,https://www.linkedin.com/feed/update/urn:li:activity:7422903255632044032/
9. February 2026,South African Health Products Regulatory Authority,Guidance,Type II Pilot Variation Applications: Submission Window and Fee Processing Clarification,https://www.linkedin.com/feed/update/urn:li:activity:7422905057135718400/
9. February 2026,South African Health Products Regulatory Authority,Guidance,Notification of an Update to the Product List(s) of a Medical Device Establishment Licence Clarifies the regulatory pathway for updating product lists linked to a Medical Device Establishment Licence.,https://www.linkedin.com/feed/update/urn:li:activity:7422907691263717376/
9. February 2026,Swissmedic,Guidance,Swissmedic Change of Name or Domicile of the Authorisation Holder,https://www.linkedin.com/feed/update/urn:li:activity:7424702930412519424/
9. February 2026,Swissmedic,Guidance,Swissmedic eIAM Portal Administrator Information Sheet Defines responsibilities and procedures for eIAM Portal Administrators at companies interacting with Swissmedic,https://www.linkedin.com/feed/update/urn:li:activity:7424705329843830786/
9. February 2026,Swissmedic,Guidance,Swissmedic swissdamed - UDI Data Dictionary (Public Use),https://www.linkedin.com/feed/update/urn:li:activity:7424707338269274112/
9. February 2026,Swissmedic,Guidance,Swissmedic Authorisation of co-marketing medicinal product Defines requirements and procedures for the authorisation and lifecycle management of co-marketing medicinal products in Switzerland,https://www.linkedin.com/feed/update/urn:li:activity:7424780743526051840/
9. February 2026,Swissmedic,Guidance,Schweizerische Gute Praxis fur die Instandhaltung von Medizinprodukten (GPI) Version 2 (2025),https://www.linkedin.com/feed/update/urn:li:activity:7422897946884636672/
9. February 2026,Swissmedic,Report,Medical Devices Swissmedic inspects Swiss importers Reports results of a Swissmedic focus inspection campaign targeting medical device importers in Switzerland,https://www.linkedin.com/feed/update/urn:li:activity:7422900475647209472/
9. February 2026,Swissmedic,Guidance,Safety in filler treatment is a priority Swissmedic and cantonal authorities conducted a coordinated focus campaign in 2025 to improve safety in filler treatments.,https://www.linkedin.com/feed/update/urn:li:activity:7424323388879327233/
9. February 2026,Swissmedic,Guidance,Drug Safety Signals HMP (Version 10.0),https://www.linkedin.com/feed/update/urn:li:activity:7424350794075774977/
9. February 2026,Therapeutic Goods Administration,Guidance,"Exporting medicines from Australia Provides comprehensive regulatory guidance for exporting prescription, OTC, and complementary medicines from Australia",https://www.linkedin.com/feed/update/urn:li:activity:7422889262813200384/
9. February 2026,Therapeutic Goods Administration,Guidance,Therapeutic Goods Administration Making over-the-counter (OTC) new medicine N1 applications Provides guidance on OTC N1 new medicine applications under section 23 of the Therapeutic Goods Act 1989,https://www.linkedin.com/feed/update/urn:li:activity:7422891843933306880/
9. February 2026,USA Food & Drug Administration FDA,Guidance,FDA Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions,https://www.linkedin.com/feed/update/urn:li:activity:7424692369150627840/
9. February 2026,USA Food & Drug Administration FDA,Guidance,"FDA Computer Software Assurance for Production and Quality System Software Draft guidance proposing a modernized, risk-based approach to software validation under 21 CFR 820.70(i)",https://www.linkedin.com/feed/update/urn:li:activity:7424693870246068224/
9. February 2026,USA Food & Drug Administration FDA,Guidance,Clinical Decision Support Software Defines FDAs current regulatory approach to Clinical Decision Support (CDS) software used by health care professionals (HCPs),https://www.linkedin.com/feed/update/urn:li:activity:7422885186423394304/
9. February 2026,USA Food & Drug Administration FDA,Guidance,FDA Computer Software Assurance for Production and Quality Management System,https://www.linkedin.com/feed/update/urn:li:activity:7425416277403439106/
9. February 2026,USA Food & Drug Administration FDA,Report,FDA CDRH International Harmonization Annual Assessment 2025,https://www.linkedin.com/feed/update/urn:li:activity:7422961423284170752/
9. February 2026,World Health Organization,Guidance,"World Health Organization WHO Drug Information Volume 39, Number 4 (2025)",https://www.linkedin.com/feed/update/urn:li:activity:7424315712346836992/
9. February 2026,World Health Organization,Guidance,World Health Organization Scaling innovations in public health systems: Guidance and toolkit,https://www.linkedin.com/feed/update/urn:li:activity:7424338445449203713/





